<DOC>
	<DOCNO>NCT02998931</DOCNO>
	<brief_summary>Glutamine supplementation beneficial effect morbidity mortality critically ill patient , possibly part attenuation proinflammatory cytokine response Immune function . In trial intensive care unit patient enteral feed receive either enteral glutamine maltodextrin placebo 28 day .</brief_summary>
	<brief_title>Trial Enteral Glutamine Clinical Outcomes Critically Ill Patients</brief_title>
	<detailed_description>A randomized , double blind , control trial conduct general intensive care unit ( ICU ) Tehran , Iran . After full review inclusion exclusion criterion explanation risk benefit study , write consent form complete . The participant 200 eligible hospitalize patient enteral feed ICU , age â‰¥ 18 year . Intervention patient receive 0.3 g/kg/day glutamine along enteral formula 28 day control patient receive maltodextrin along enteral formula 28 day . Patients evaluate occurrence new infection , organ failure , duration stay ICU , 28 day 6 month mortality inflammatory immune marker .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Multiple Organ Failure</mesh_term>
	<criteria>Adult patient ( &gt; 18 year old ) admit ICU Start study intervention within 48 hour ICU admission Expected require enteral nutrition least 72 hour aim full enteral nutrition receive least 80 percent enteral formula first 48 hour Written inform consent patient write informed consent legal representative Enrollment relate ICU interventional study Requiring specific enteral nutrition medical reason Death Discharge 5th day Having contraindication receive enteral nutrition Pregnant patient lactate intent breastfeed Requiring specific enteral nutrition medical reason BMI &lt; 18 &gt; 40.0 kg/m2 Have life expectancy &lt; 6 mo Patients moribond Liver cirrhosis Child 's class C liver disease Have seizure disorder require anticonvulsant History allergy intolerance study product component Receiving glutamine two week start study product Have reason</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Glutamin</keyword>
	<keyword>Enteral Nutrition</keyword>
	<keyword>Intensive Care Unit</keyword>
	<keyword>Critical Care Outcomes</keyword>
	<keyword>inflammatory</keyword>
	<keyword>Immune System</keyword>
</DOC>